Front Row Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.39K Hold
40
﹤0.01% 411
2025
Q4
$11.4K Hold
40
﹤0.01% 363
2025
Q3
$12.3K Hold
40
﹤0.01% 358
2025
Q2
$12.6K Hold
40
﹤0.01% 348
2025
Q1
$10.5K Hold
40
﹤0.01% 355
2024
Q4
$10.4K Hold
40
﹤0.01% 358
2024
Q3
$9.31K Hold
40
﹤0.01% 371
2024
Q2
$8.07K Hold
40
﹤0.01% 632
2024
Q1
$6.86K Hold
40
﹤0.01% 670
2023
Q4
$8.68K Hold
40
﹤0.01% 342
2023
Q3
$6.38K Hold
40
﹤0.01% 617
2023
Q2
$12K Hold
40
0.01% 485
2023
Q1
$13K Hold
40
0.01% 469
2022
Q4
$12K Hold
40
0.01% 463
2022
Q3
$9K Hold
40
﹤0.01% 525
2022
Q2
$9K Hold
40
﹤0.01% 538
2022
Q1
$11K Hold
40
﹤0.01% 537
2021
Q4
$11K Hold
40
﹤0.01% 558
2021
Q3
$11K Hold
40
﹤0.01% 543
2021
Q2
$12K Hold
40
﹤0.01% 523
2021
Q1
$10K Hold
40
﹤0.01% 554
2020
Q4
$10K Sell
40
-22
-35% -$5.46K 0.01% 528
2020
Q3
$16K Sell
62
-2
-3% -$421 0.01% 416
2020
Q2
$12K Hold
64
0.01% 435
2020
Q1
$13K Buy
64
+4
+7% +$731 0.01% 411
2019
Q4
$10K Hold
60
0.01% 456
2019
Q3
$10K Buy
60
+5
+9% +$703 0.01% 443
2019
Q2
$7K Sell
55
-60
-52% -$6.15K 0.01% 516
2019
Q1
$11K Buy
115
+15
+15% +$1.29K 0.01% 428
2018
Q4
$8K Hold
100
0.01% 444
2018
Q3
$8 Buy
100
+40
+67% +$3.75K 0.01% 467
2018
Q2
$5 Sell
60
-26
-30% -$2.33K ﹤0.01% 609
2018
Q1
$7K Buy
+86
New +$6.68K ﹤0.01% 499

Other funds holding PODD

Front Row Advisors's PODD Position: Q1 2026 in Review

Front Row Advisors held its Insulet (PODD) position steady in Q1 2026 at 40 shares worth $8.39K. The position accounts for ﹤0.01% of the portfolio, ranked #411.

Front Row Advisors first reported a position in PODD in Q1 2018 and has held it in 33 quarters since. The position peaked at $16K in Q3 2020. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Front Row Advisors held 40 shares of Insulet worth $8.39K as of Q1 2026.
  • Front Row Advisors left its Insulet share count unchanged in Q1 2026.
  • Insulet made up ﹤0.01% of Front Row Advisors's portfolio in Q1 2026, its #411 holding.
  • Front Row Advisors first reported a position in Insulet in Q1 2018 and has held it in 33 quarters since.
  • Front Row Advisors's Insulet position peaked at $16K in Q3 2020.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.